Enhanced Perinatal Surveillance United States, 1999–2001
HIV/AIDS Surveillance Special Report - Number 4
On this Page
Contents
Figures and Tables |
|
|---|---|
| Figure 1 | Location of Enhanced Perinatal Surveillance Project Sites, 1999–2001 |
| Table 1 | Number and percentage of pregnant women with HIV infection who gave birth to a live infant, by year of infant’s birth and selected characteristics of mother, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 2 | Prenatal care of HIV-infected women, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 3 | Timing of HIV testing of HIV-infected women, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 4 | Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 5 | Method of delivery for HIV-infected women, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 6 | Substance use and toxicology screening of HIV-infected women during pregnancy, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 7 | Screening of HIV-infected women during pregnancy, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 8 | Number and percentage of HIV-infected women with positive test results for selected conditions, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 9 | Prenatal care of HIV-infected women, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 10 | Timing of HIV testing of HIV-infected women, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 11 | Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt, race/ethnicity, and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 12 | Method of delivery for HIV-infected women, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 13 | Substance use and toxicology screening of HIV-infected women during pregnancy, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 14 | Type of birth, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 15 | Number and percentage of infants receiving prophylaxis against Pneumocystis carinii pneumonia, by year of birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| Table 16 | Number and percentage of infants infected with HIV through mother-to-child transmission, as of October 2003, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
Download document:
